95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.01%
Revenue growth at 75-90% of NEM's 20.20%. Bill Ackman would push for innovation or market expansion to catch up.
42.43%
Gross profit growth under 50% of NEM's 91.34%. Michael Burry would be concerned about a severe competitive disadvantage.
173.43%
EBIT growth 50-75% of NEM's 232.89%. Martin Whitman would suspect suboptimal resource allocation.
173.43%
Operating income growth at 50-75% of NEM's 232.89%. Martin Whitman would doubt the firm’s ability to compete efficiently.
160.92%
Net income growth under 50% of NEM's 8812.00%. Michael Burry would suspect the firm is falling well behind a key competitor.
160.71%
EPS growth under 50% of NEM's 8259.51%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
160.71%
Diluted EPS growth under 50% of NEM's 8228.83%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.23%
Share reduction more than 1.5x NEM's 7.05%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.31%
Diluted share reduction more than 1.5x NEM's 7.03%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-48.78%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
30.24%
OCF growth under 50% of NEM's 164.55%. Michael Burry might suspect questionable revenue recognition or rising costs.
30.44%
FCF growth under 50% of NEM's 548.15%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
124.83%
Positive 10Y revenue/share CAGR while NEM is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
8.13%
Positive 5Y CAGR while NEM is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-5.44%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
119.98%
Positive long-term OCF/share growth while NEM is negative. John Neff would see a structural advantage in sustained cash generation.
-5.19%
Negative 5Y OCF/share CAGR while NEM is at 48.57%. Joel Greenblatt would question the firm’s operational model or cost structure.
-13.15%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
58.76%
Below 50% of NEM's 235.44%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
1255.10%
5Y net income/share CAGR above 1.5x NEM's 522.25%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
-9.73%
Negative 3Y CAGR while NEM is 493.96%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
121.53%
10Y equity/share CAGR above 1.5x NEM's 29.05%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
15.88%
5Y equity/share CAGR at 50-75% of NEM's 25.62%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
3.35%
Below 50% of NEM's 25.00%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
45.92%
Below 50% of NEM's 410.23%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
66.54%
Below 50% of NEM's 404.17%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
156.25%
AR growth well above NEM's 16.92%. Michael Burry fears inflated revenue or higher default risk in the near future.
No Data
No Data available this quarter, please select a different quarter.
0.29%
Asset growth well under 50% of NEM's 10.21%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.52%
Under 50% of NEM's 3.09%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-7.47%
We’re deleveraging while NEM stands at 11.71%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
7.56%
SG&A growth well above NEM's 3.70%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.